Risk of cardiac‐related mortality in stage <scp>IIIA‐N2</scp> non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database

Abstract

With a median follow-up of 25 months, no significant differences were found in cardiac-related mortality between the PORT and Non-PORT groups in stage IIIA-N2 NSCLC patients.